Anti-ELMO1 antibodies are used in the immunodetection of the protein engulfment and cell motility 1. In humans, the canonical protein has a reported length of 727 amino acid residues and a mass of 83.8 kDa. Its subcellular localization is in the cell membrane and cytoplasm. Up to 3 different isoforms have been reported for this protein. It is found to be widely expressed, with a higher expression in the spleen and placenta. ELMO1 is known to be involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Post-translational modifications have been described, including phosphorylation. Synonyms for this target antigen include CED12, engulfment and cell motility protein 1, ced-12 homolog 1, and CED-12. ELMO1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of ELMO1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunofluorescence are also common applications.